In comparison to CaL-based signaling, T-type calcium channel (CaT) activity in the context of PAH is relatively unexplored, partly due to a historical lack of specific pharmacological inhibitors (Perez-Reyes, 2003; Kuo et al., 2011). This evidence concerns the gene CAT and pulmonary arterial hypertension.